Abstract
Twelve non-replicate Acinetobacter baumannii isolates from five European hospitals, Kuwait, and the US military healthcare system collected between 1980 and 2005 revealed a new clone, CC32. These included representative isolates of outbreaks/cross-infections. Antimicrobial susceptibility and carbapenem-resistant genetic traits varied. The widespread occurrence, the association with an outbreak and the carbapenem resistance indicate that CC32 has epidemic potential.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acinetobacter Infections / epidemiology
-
Acinetobacter Infections / microbiology*
-
Acinetobacter baumannii / classification*
-
Acinetobacter baumannii / drug effects
-
Acinetobacter baumannii / genetics
-
Acinetobacter baumannii / isolation & purification
-
Anti-Bacterial Agents / pharmacology
-
Disease Outbreaks
-
Drug Resistance, Multiple, Bacterial
-
Europe / epidemiology
-
Humans
-
Kuwait / epidemiology
-
Military Personnel / statistics & numerical data
-
United States